Ferric Carboxymaltose

Dosage Forms Available

• Ferric Carboxymaltose is available as a dark brown, sterile, aqueous solution for administration via the intravenous route.

Age and Dose Restrictions

• This medication is intended for use in adults and in children aged 1 year and older.

Contraindications

• The use of Ferric Carboxymaltose is contraindicated in patients with known hypersensitivity to the medication or any of its excipients.
• It is also contraindicated in patients with a history of allergic disorders, including asthma, eczema or atopic allergies.
• Ferric Carboxymaltose should not be used in patients with anaemia not caused by iron deficiency, those with evidence of iron overload and patients who are less than 1 year old.

Other Medications to Avoid

• Ferric Carboxymaltose may interact with oral iron supplements as these may reduce the absorption of oral iron preparations.
• It can also interact with tetracyclines (doxycycline, minocycline) and fluoroquinolones (ciprofloxacin, ofloxacin), so these should be taken at least 1 hour before or 2 hours after Ferric Carboxymaltose administration.

Overdose and Missed Dose

• An overdose of Ferric Carboxymaltose may result in iron overload which can lead to various complications. If you suspect you have received an overdose, contact your doctor immediately.
• If you miss a dose of this medication, consult your doctor for advice on how to proceed.

Management of Side Effects

Most side effects are temporary and generally harmless and resolve after discontinuing this medicine. However, if you experience any severe side effects or worsening of any symptoms, please consult your doctor.

• Drinking plenty of fluids may help manage side effects such as dizziness.
• Resting after administration may help manage feelings of fatigue.

Use in Driving and Operating Machinery

• Ferric Carboxymaltose may cause dizziness or fainting. It is advised to avoid driving or operating heavy machinery if you experience these side effects.

Use in Pregnancy and Lactation

• The use of Ferric Carboxymaltose during pregnancy should be considered only if the potential benefit justifies the potential risk.
• Breastfed infants of mothers treated with Ferric Carboxymaltose should be monitored for gastrointestinal adverse effects.

Caution in Other Conditions

• Caution is advised when using Ferric Carboxymaltose in patients with acute or chronic infections, asthma, eczema, other atopic allergies, liver dysfunction or disease, systemic lupus erythematosus, and in patients with rheumatoid arthritis.

Special Dietary and Lifestyle Recommendations

• Maintaining a balanced diet rich in iron can help manage iron deficiency anaemia.
• Regular check-ups with your doctor are recommended to monitor your iron levels and adjust the dosage of Ferric Carboxymaltose as needed.
• Avoid alcohol consumption during treatment as alcohol can interfere with the absorption of iron.
• Maintain regular physical activity, as this can help promote the production of red blood cells.
• Remember that these recommendations are general in nature and you should always consult your doctor for personalised advice based on your condition and treatment plan.